HFPN animation highlighting the importance of guideline-based care now available with subtitles in five languages

News & Events

22 July 2022
AUTHOR: HFPN Admin

HFPN has added subtitles to a recently launched animation that aims to raise awareness of the urgent need to increase access to guideline-recommended care. The addition of subtitles in five languages – German, English, French, Italian and Spanish – make the video accessible for a wider range of audiences across Europe.

The animation highlights the importance of best-practice care for heart failure and what this could achieve for people living with the syndrome. It accompanies our recent report From guidelines to action: opportunities for change following the 2021 European Society of Cardiology heart failure guidelines, which gives an accessible overview of the key ways in which following the European Society of Cardiology guidelines can improve the lives and outcomes of people living with heart failure.

Effective, evidence-based treatments exist for heart failure – yet nearly 30% of people living with the syndrome in Europe are not receiving guideline-based care. While the availability and quality of heart failure care has improved across Europe over recent years, there remain inequalities in service provision, with many countries lacking trained healthcare professionals, reimbursement for diagnostic tests and treatment, and dedicated management programmes.

We invite the heart failure advocacy community to share the animation via your social media channels, in presentations or at events.

 

English

 

French

 

German

 

Italian

 

Spanish

 

Tagged:

More from News & Events

9 things we learnt from the Heart Failure Policy Summit 2022
9 things we learnt from the Heart Failure Policy Summit 2022...
13 January 2023
Last year's Summit brought together experts from the heart failure and wider health advocacy communities. Here, we reflect on some learning points....
Read article
Innovation in heart failure: how can we ensure early diagnos
Innovation in heart failure: how can we ensure early diagnos...
08 December 2022
Our ‘Innovation in heart failure: early diagnosis in community settings’ report outlines the urgent need to boost timely diagnosis and presents a variety of promising initiativ...
Read article
The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from AstraZeneca, CSL Vifor, Boehringer Ingelheim and Roche Diagnostics. The content produced by the Network is not biased toward any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members. All members provide their time for free. The Network is hosted by The Health Policy Partnership .